Latest Psoriasis Stories
Lexington Int’l is pleased to announce that it has received FDA 510K Marketing Clearance for 2 new HairMax enhanced, hands-free laser phototherapy devices.
First Presentation of Phase 3 Data From Brodalumab Psoriasis Program THOUSAND OAKS, Calif. and LONDON, Dec.
DELHI, India, December 9, 2014 /PRNewswire/ -- Access to this therapy will impact 12 million people suffering from auto immune disorders like rheumatoid arthritis,
Frontier Pharma - NSCLC - Identifying and Commercializing First-in-Class Innovation in Non-Small-Cell Lung Carcinoma provides information on pricing, market analysis, shares, forecast, and company
PETACH TIKVA, Israel, Dec. 1, 2014 /PRNewswire/ -- Can-Fite BioPharma Ltd.
DailyGossip.org publishes a review for patients diagnosed with psoriasis.
Study Met All Primary Endpoints Against Stelara® (ustekinumab) and Placebo THOUSAND OAKS, Calif. and LONDON, Nov.
Akron cosmetic dermatologist, Dr. James Libecco, MD, opened Akron Skin Center back in 2009 AKRON, Ohio, Nov.
According to Dermatologists Dr. Joshua Fox and Dr. Robert Levine, Psoriasis and Eczema are painful.
Treatment for lifelong skin disease that affects nearly a million Canadians showed significant and clinically meaningful improvements in clinical studies Canadian approval comes
- A ceramic container used inside a fuel-fired kiln to protect pots from the flame.